Researchers who have developed cutting-edge medical technologies or pharmaceuticals can soon apply for funding to help bring those discoveries to market.
The University of Minnesota’s MN-REACH program, part of the National Institutes of Health’s Research Evaluation and Commercialization Hubs, is now entering its fourth funding cycle to help commercialize new med-tech and pharma inventions. MN-REACH aims to improve health care by fostering the development of breakthrough lab innovations — such as therapeutics, preventatives, diagnostics, devices and software tools — into products that create health, economic and societal benefits.
Researchers can submit pre-proposals from Thursday, July 14 through Friday, Aug. 12. Funding is available in the range of $10,000 to $150,000 per project. See the list of projects selected for MN-REACH funding during Cycle 1 and Cycle 2. Awardees of Cycle 3 grants will be announced later this month.
In addition to providing funding opportunities to commercialize innovations, MN-REACH offers educational opportunities for innovators looking to develop their products and form new partnerships both within and beyond the University.
Registration is now open for the free Medical Technology Commercialization Bootcamp, to be held on Wednesday, Aug. 3 from 10 a.m. to 4 p.m. University faculty, staff and student health care researchers are invited to attend to learn about the commercialization process and the resources available to support bringing an innovation to market.
Contact email@example.com with questions.